Aurora Cannabis (ACB) Income from Non-Controlling Interests (2018 - 2025)

Aurora Cannabis (ACB) reported Income from Non-Controlling Interests of $22.6 million for Q4 2025, up 9768.83% year-over-year from $228637.4 in Q4 2024, and down 11.76% quarter-over-quarter from $25.6 million in Q3 2025.

Aurora Cannabis (ACB) Income from Non-Controlling Interests (2018 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has 8 years of Income from Non-Controlling Interests data on file, last reported at $22.6 million in Q4 2025.

  • Income from Non-Controlling Interests for Q4 2025 came in at $22.6 million, up 9768.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $22.6 million (up 1468.42% YoY), and the FY2025 annual result was $28.9 million, up 1138.93% from the prior year.
  • Income from Non-Controlling Interests fell to $22.6 million in Q4 2025 per ACB's latest filing, from $25.6 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $30.7 million in Q4 2023 and troughed at -$1.3 million in Q4 2022.
  • A 5-year average of $8.8 million and a median of $264934.4 in 2024 frame the typical range for Income from Non-Controlling Interests.
  • On a YoY basis, Income from Non-Controlling Interests climbed as much as 1455025.06% in 2023 and fell as far as 451.4% in 2023.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $395081.4 in 2021, then slumped by 433.97% to -$1.3 million in 2022, then jumped by 2423.69% to $30.7 million in 2023, then plunged by 100.76% to -$233366.8 in 2024, then soared by 9768.83% to $22.6 million in 2025.
  • Business Quant data shows ACB's Income from Non-Controlling Interests at $22.6 million in Q4 2025, $25.6 million in Q3 2025, and $26.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 22.56 Mn
Sep 30, 2025 25.57 Mn
Jun 30, 2025 26.53 Mn
Mar 31, 2025 1.36 Mn
Dec 31, 2024 -233,366.82
Sep 30, 2024 -677,341.35
Jun 30, 2024 -1.00 Mn
Mar 31, 2024 264,934.42
Dec 31, 2023 30.66 Mn
Sep 30, 2023 -1.20 Mn
Jun 30, 2023 23.97 Mn
Mar 31, 2023 22.98 Mn
Dec 31, 2022 -1.32 Mn
Sep 30, 2022 -216,989.19
Jun 30, 2022 8,627.75
Mar 31, 2022 1,578.95
Dec 31, 2021 395,081.37
Sep 30, 2020 -1.10 Mn
Jun 30, 2020 -17.57 Mn
Mar 31, 2020 -14.78 Mn